230 related articles for article (PubMed ID: 9737647)
1. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
Mabuchi H; Koizumi J; Kajinami K
Am J Cardiol; 1998 Aug; 82(4B):52J-55J. PubMed ID: 9737647
[TBL] [Abstract][Full Text] [Related]
2. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
Farnier M
Am J Cardiol; 1998 Aug; 82(4B):47J-51J. PubMed ID: 9737646
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
Leitersdorf E; Muratti EN; Eliav O; Peters TK
Am J Cardiol; 1995 Jul; 76(2):84A-88A. PubMed ID: 7604807
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.
Leitersdorf E; Muratti EN; Eliav O; Meiner V; Eisenberg S; Dann EJ; Sehayek E; Peters TK; Stein Y
Am J Med; 1994 May; 96(5):401-7. PubMed ID: 8192170
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
7. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
Hunninghake DB
Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643
[TBL] [Abstract][Full Text] [Related]
9. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
[TBL] [Abstract][Full Text] [Related]
12. High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.
Eliav O; Schurr D; Pfister P; Friedlander Y; Leitersdorf E
Am J Cardiol; 1995 Jul; 76(2):76A-79A. PubMed ID: 7604804
[TBL] [Abstract][Full Text] [Related]
13. [A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia].
Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
Rev Med Interne; 1999 Aug; 20 Suppl 3():393s-398s. PubMed ID: 10480191
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia.
Kajinami K; Yagi K; Higashikata T; Inazu A; Koizumi J; Mabuchi H
Am J Cardiol; 1998 Jul; 82(1):113-7. PubMed ID: 9671018
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
Peters TK
Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803
[TBL] [Abstract][Full Text] [Related]
16. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
17. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006401. PubMed ID: 28685504
[TBL] [Abstract][Full Text] [Related]
18. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group.
Dujovne CA; Knopp R; Kwiterovich P; Hunninghake D; McBride TA; Poland M
Mayo Clin Proc; 2000 Nov; 75(11):1124-32. PubMed ID: 11075741
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemia.
Koizumi J; Haraki T; Yagi K; Inazu A; Kajinami K; Miyamoto S; Ueda K; Ohta M; Takegoshi T; Takeda M
Am J Cardiol; 1995 Jul; 76(2):47A-50A. PubMed ID: 7604797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
